百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

已收盘 09-04 16:08:03

60.600

-3.550

-5.53%

最高65.150	最低59.900	成交量163.20万
今开64.200	昨收64.150	日振幅8.18%
总市值270.88亿	流通市值67.27亿	总股本4.47亿
成交额1.00亿	换手率1.47%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":60.6,"timestamp":1788509283003,"preClose":64.15,"halted":0,"volume":1631986,"delay":0,"changeRate":-0.05533904910366335,"floatShares":111000000,"shares":447000000,"eps":0.5024910027520993,"marketStatus":"已收盘","change":-3.55,"latestTime":"09-04 16:08:03","open":64.2,"high":65.15,"low":59.9,"amount":100235922,"amplitude":0.081839,"askPrice":60.65,"askSize":1000,"bidPrice":60.6,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":0.9511500275209935,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":64.15,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":0.649152,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":119.89,"timestamp":1788505200000,"preClose":127.08,"halted":0,"volume":2552900,"delay":0,"premium":"-56.75"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"2664782740","title":"百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2664782740","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664782740?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:23","pubTimestamp":1788416580,"startTime":"0","endTime":"0","summary":"北京2026年9月3日 /美通社/ -- 百奥赛图（北京）医药科技股份有限公司于2026年9月2日宣布，公司近期与齐鲁制药有限公司签署全人纳米抗体分子非排他授权合作协议。根据协议，百奥赛图将向齐鲁制药授权一款全人纳米抗体分子，用于支持其在神经领域创新药物项目中的研发探索。通过此次授权，齐鲁制药可结合其自身研发策略，对相关纳米抗体分子开展进一步研究和开发，后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1574","MEDX","688796","IBBQ","LNGR","01477","BK1161","06978","BK1191","02315","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664895350","title":"港股午评|恒生指数早盘跌0.96%      黄金股延续跌势","url":"https://stock-news.laohu8.com/highlight/detail?id=2664895350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664895350?lang=zh_cn&edition=full","pubTime":"2026-09-02 12:00","pubTimestamp":1788321653,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数跌0.96%，跌242点，报25087点；恒生科技指数跌1.54%。港股早盘成交1196亿港元。二季度归母净利同比增长83%，储能业务保持较快增长。新意网集团绩后涨超16%，全年股东应占溢利11.46亿港元，同比增加16.96%。汽车股跌幅居前。三部门发布汽车行业境外竞争指引，避免海外市场多频大幅降价。集运股全线下跌。黄金股延续跌势。加息预期攀升压制贵金属，现货黄金跌破4310美元。潼关黄金跌5.36%；灵宝黄金跌3.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU0307460666.USD","07200","BK4588","BK1506","07300","BK1523","VXUS","LU0588546209.SGD","159271","03419","83115","HSI","02315","07500","159562","HHImain","KCAI","BK1149","03115","03037","09115","HSImain","02833","MCHmain","GLDW","SG9999006597.SGD","06869","02800","MHImain","BK4585","513600","82800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664898242","title":"港股异动 | 百奥赛图-B(02315)涨超13% 上半年核心业务维持高速增长 AI赋能加速平台兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2664898242","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664898242?lang=zh_cn&edition=full","pubTime":"2026-09-02 10:41","pubTimestamp":1788316899,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B涨超13%，截至发稿，涨11.61%，报63.95港元，成交额1.03亿港元。消息面上，凭借“全人抗体库”与“靶点人源化小鼠库”双引擎的深度协同，百奥赛图不仅实现了营收与利润的全面跃升，更是连续5个季度保持盈利。报告期内，临床前板块总营收7.23亿元，同比增长57.9%，其中创新动物模型销售收入4.46亿元，同比增长62.4%，毛利率82.3%；抗体开发业务实现收入2.18亿元，同比增长33.8%，并维持了92.8%的高毛利率水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","QTOC","ARTY","BK4588","KCAI","BK4585","VXUS","AIPO","BK1161","688796","VTHR","AGIX","BK0216","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134555285","title":"异动解读｜百奥赛图-B盘中上涨12.74%，中期业绩大增叠加机构持续加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=1134555285","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134555285?lang=zh_cn&edition=full","pubTime":"2026-09-02 10:23","pubTimestamp":1788315789,"startTime":"0","endTime":"0","summary":"9月2日，百奥赛图-B盘中上涨12.74%，报64.6港元，成交额8673.58万港元。消息面上，公司于8月27日发布中期业绩，上半年实现营收9.41亿元，同比增长51.6%；归母净利润2.41亿元，同比大增402.3%，已连续5个季度盈利，整体毛利率由74.4%提升至79.3%。其中临床前产品与服务收入7.23亿元，同比增长57.9%；抗体发现业务收入2.18亿元，毛利率高达92.8%。此外，富国基金于8月28日以每股约60.17港元增持53.6万股，持股比例升至8.29%；此前易方达基金亦多次增持，持股比例已达10.0%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百奥赛图盘中上涨，中期业绩大增引机构加仓","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085571","title":"富国基金管理有限公司增持百奥赛图(02315)53.6万股 每股作价约60.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085571","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664085571?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:40","pubTimestamp":1788262828,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，8月28日，富国基金管理有限公司增持百奥赛图(02315)53.6万股，每股作价60.1705港元，总金额约为3225.14万港元。增持后最新持股数目约为918.61万股，最新持股比例为8.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688796","02315","EWH","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166300554","title":"百奥赛图-B（02315）将于9月9日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1166300554","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166300554?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:27","pubTimestamp":1788254869,"startTime":"0","endTime":"0","summary":"百奥赛图（北京）医药科技股份有限公司9月1日发布海外监管公告称，公司拟于2026年9月9日（星期三）16:30-17:30以网络文字互动形式召开2026年半年度业绩说明会。本次说明会将围绕2026年上半年经营成果及财务指标与投资者进行交流，并就普遍关注的问题在信息披露允许范围内进行答复。如有特殊情况，参会人员或将调整。会后，投资者可通过进门财经平台查看本次说明会的召开情况及主要内容。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146303499","title":"百奥赛图-B：富国基金管理有限公司增持，好仓比例升至8.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146303499","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146303499?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:14","pubTimestamp":1788254056,"startTime":"0","endTime":"0","summary":"富国基金管理有限公司于2026年8月28日以每股均价60.1705港元买入百奥赛图-B股份53.60万股，涉资约3225.14万港元。富国基金管理有限公司此次增持前持有百奥赛图-B好仓865.01万股，占比7.81%；增持后持股量为918.61万股，好仓比例升至8.29%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114503512","title":"百奥赛图-B8月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1114503512","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114503512?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:33","pubTimestamp":1788251592,"startTime":"0","endTime":"0","summary":"2026年9月1日，百奥赛图(北京)医药科技股份有限公司（简称“百奥赛图-B”，股票代码：02315）发布截至2026年8月31日的月度股份变动报告。\n报告显示，截至2026年8月31日，公司法定/注册股本总额为人民币446,898,420元，包含H股110,781,920股及A股336,116,500股。与上月底相比，报告期内无新增股份发行、购回、注销或库藏股变动，公司股本结构继续保持稳定。\n公告同时指出，公司已符合香港联合交易所有限公司《上市规则》下的相关公众持股量要求。上述公告由联席公司秘书王永亮签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127902430","title":"百奥赛图-B发布2026年中期业绩：营收9.41亿元 同比增逾五成","url":"https://stock-news.laohu8.com/highlight/detail?id=1127902430","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127902430?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:51","pubTimestamp":1787831465,"startTime":"0","endTime":"0","summary":"报告期内，公司实现营业收入9.41亿元，同比增长51.60%；归属于母公司股东的净利润2.41亿元，同比大幅增长402.29%。期内，公司营业总成本7.04亿元，其中营业成本1.95亿元，销售费用0.76亿元，管理费用1.14亿元，研发费用2.67亿元，同比增加27.85%，研发投入占营业收入的28.40%。业务分部方面，公司临床前产品与服务实现营业收入7.23亿元，同比增长57.94%；创新动物模型销售收入4.46亿元，同比增加62.44%。抗体发现业务实现营业收入2.18亿元，同比增长33.77%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119245307","title":"百奥赛图-B（02315）拟9月16日召开第三次临时股东会 审议募投项目调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1119245307","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119245307?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:53","pubTimestamp":1787820782,"startTime":"0","endTime":"0","summary":"股东将就该议案进行表决，结果将按港交所上市规则以投票方式公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774502","title":"百奥赛图-B(02315)发布中期业绩，股东应占盈利2.41亿元，同比增长402.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774502","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662774502?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:39","pubTimestamp":1787819961,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B 发布截至2026年6月30日止六个月业绩，收益9.41亿元，同比增长51.6%;公司权益股东应占盈利2.41亿元，同比增长402.3%;每股基本盈利0.54元。2026年上半年，以创新动物模型销售为核心的临床前产品与服务业务实现营业收入人民币7.235亿元，较去年同期增长57.9%，同时毛利率保持在70%以上的高水平。通过AI及自动化智造平台赋能，抗体发现业务2026年上半年实现营业收入人民币2.179亿元，较去年同期增长33.8%，毛利率约92.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","02315","BK1161","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149449431","title":"百奥赛图-B2026年中期业绩：营收9.41亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149449431","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149449431?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:37","pubTimestamp":1787819854,"startTime":"0","endTime":"0","summary":"根据百奥赛图（北京）医药科技股份有限公司发布的2026年中期业绩公告，期内实现营收9.41亿元，同比增长51.6%。本期毛利达7.46亿元，较上年同期上升61.6%，整体毛利率从74.4%提升至79.3%。同期经营利润为3.05亿元，经营利润率约32.4%。期间，销售及营销开支约0.76亿元，较上年同期增加30.3%；一般及行政开支约1.33亿元，同比增长14.5%；研发开支约2.67亿元，同比增长27.8%，占主营收入的比重约30%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百奥赛图-B2026年中期业绩：营收9.41亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165076172","title":"异动解读｜百奥赛图-B盘中下跌6.31%，财报发布在即叠加生物科技板块普跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1165076172","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165076172?lang=zh_cn&edition=full","pubTime":"2026-08-24 10:43","pubTimestamp":1787539422,"startTime":"0","endTime":"0","summary":"8月24日，百奥赛图-B盘中下跌6.31%，报60.9港元/股，成交额2531.79万港元。消息面上，公司中期业绩将于8月27日发布，此前已预告上半年归母净利润同比增长392%至413%，但有机构观点对本季度展望偏谨慎，指出缺乏明确的营收指引与一致预期。同时生物科技板块整体承压，康方生物跌1.11%，信达生物跌3.12%，百济神州跌3.42%，康希诺生物跌4.68%，板块联动效应加大个股调整压力。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"百奥赛图-B盘中下跌，财报在即板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140418972","title":"异动解读｜百奥赛图-B盘中上涨5.71%，中报业绩预增超4倍叠加财报发布在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1140418972","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140418972?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:49","pubTimestamp":1787190540,"startTime":"0","endTime":"0","summary":"8月20日，百奥赛图-B盘中上涨5.71%，报63.7港元/股，成交额2731.56万港元。消息面上，公司此前发布中期业绩预告，预计上半年归母净利润2.36亿至2.46亿元，同比增长392%至413%；营业收入9.36亿至9.46亿元，同比增长51%至52%。公司董事会将于8月27日召开会议审议中期业绩并考虑派发中期股息。本次上涨或为8月17日下跌7.83%后的修复，叠加财报发布临近，市场对业绩高增长的预期推动股价反弹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百奥赛图-B盘中上涨5.71%，中报业绩预增超4倍叠加财报发布在即","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170431668","title":"财报前瞻｜百奥赛图-B本季度营收预计持稳，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1170431668","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170431668?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:16","pubTimestamp":1787188573,"startTime":"0","endTime":"0","summary":"百奥赛图-B计划于2026年08月27日发布最新季度财报，市场关注公司订单交付节奏与费用投放对利润率的影响。目前缺乏可验证的一致预期与公司在上个季度财报中对本季度的明确指引，未能获得关于本季度营收、毛利率、净利润或净利率、调整后每股收益的具体预测数据。公司上季度毛利率为78.88%，归属于母公司股东的净利润为1.04亿元，净利率为24.02%，环比增长率为76.11%；由于工具未提供营收与调整后每股收益以及同比数据，无法在此处展示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜百奥赛图-B本季度营收预计持稳，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153091190","title":"百奥赛图-B (02315) 计划于8月27日召开董事会审议2026年中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1153091190","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153091190?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:41","pubTimestamp":1786956089,"startTime":"0","endTime":"0","summary":"百奥赛图（北京）医药科技股份有限公司（股票代码：02315）8月17日发布公告称，公司董事会将于2026年8月27日（星期四）召开会议，拟审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩，并考虑派发中期股息（如有）。\\n\\n公告显示，公司董事会目前成员包括：董事长、首席执行官兼执行董事沈月雷博士；执行董事倪健博士；非执行董事周可祥博士、张蕾娣女士及刘弘康博士；独立非执行董事华风茂先生、喻长远博士及梁晓燕女士；以及职工董事李妍女士。\\n\\n公司表示，将在董事会会议后按规定发布2026年中期业绩公告，并同步披露是否派发中期股息的决定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124952483","title":"异动解读｜百奥赛图-B盘中下跌7.83%，报63.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124952483","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124952483?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:37","pubTimestamp":1786952257,"startTime":"0","endTime":"0","summary":"8月17日，百奥赛图-B盘中下跌7.83%，报63.6港元/股，成交额2.4亿港元。百奥赛图-B所在的生物科技行业中，个股表现分化，康方生物跌5.83%，信达生物涨1.76%，百济神州涨1.23%，三生制药跌0.57%，荣昌生物跌0.06%。百奥赛图是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司，利用其自主开发的RenMice全人源抗体和TCR小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132627557","title":"异动解读｜百奥赛图-B盘中上涨5.07%，上半年归母净利润最高预增超4倍叠加机构持续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1132627557","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132627557?lang=zh_cn&edition=full","pubTime":"2026-08-13 13:28","pubTimestamp":1786598925,"startTime":"0","endTime":"0","summary":"8月13日，百奥赛图-B盘中上涨5.07%，报70.5港元，成交额1.6亿港元。消息面上，公司此前发布业绩预告，预计上半年实现营业收入9.36亿至9.46亿元，同比增长51%至52%；归母净利润2.36亿至2.46亿元，同比增长392%至413%。此外，易方达基金持续增持公司股份，好仓比例已升至10.0%；富国基金持股比例亦升至8.23%，机构资金持续流入。公司此前与Whitehawk Therapeutics达成全球双抗ADC战略合作，模式动物与抗体开发双轮驱动，规模化盈利加速释放。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131233928","title":"异动解读｜百奥赛图-B盘中上涨5.68%，上半年归母净利润最高预增超4倍叠加机构持续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1131233928","media":"行情直击","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131233928?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:37","pubTimestamp":1786415841,"startTime":"0","endTime":"0","summary":"8月11日，百奥赛图-B盘中上涨5.68%，报72.55港元，成交额6893.85万港元。消息面上，公司近日发布业绩预告，预计上半年实现营业收入9.36亿至9.46亿元，同比增长51%至52%；归母净利润2.36亿至2.46亿元，同比增长392%至413%。此外，易方达基金持续增持公司股份，好仓比例已升至10.0%；富国基金持股比例亦升至8.23%，机构资金持续流入。公司此前与Whitehawk Therapeutics达成全球双抗ADC战略合作，模式动物与抗体开发双轮驱动，规模化盈利加速释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097936","title":"AI医疗概念股普升 剂泰科技-P（07666）涨12.86%、晶泰控股（02228）涨10.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097936","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097936?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:03","pubTimestamp":1786327392,"startTime":"0","endTime":"0","summary":"金吾财讯 | AI医疗概念股盘初普升，截至发稿，剂泰科技-P 涨12.86%，晶泰控股涨10.26%，英硅智能涨9.38%，百奥赛图-B涨8.33%，讯飞医疗科技涨4.98%，医渡科技涨4.00%，云知声涨3.96%，平安好医生涨3.58%，阿里健康涨3.21%，京东健康涨2.98%。AIDD有望重塑早期药物发现的流程，大大加速早期药物筛选的效率及成功率，相关干实验投入的增加以及对湿实验需求持续的增长，有望为下游产业链持续带来增量。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NDQ1MWJhN2NhODAzMzgwYTAyY2UxMDMzODA5NjE3NDc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987779","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1518","SGXZ62798434.SGD","02506","BK1571","BK1615","09678","BK1583","BK1142","BK1591","QTOC","06618","02228","AGIX","03696","00241","AIPO","BK1610","02158","159891","BK1161","BK1141","BK1589","SGXZ86797644.SGD","VTHR","LU0051755006.USD","07666","BK1189","BK1584","BK1247","BK1109","BK1515","CHAT","LU0456827905.SGD","BK1501","02315","BK1502","86618","HK0000165453.HKD","ARTY","BK1617","01833","BK1219"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.0656},{"period":"1month","weight":0.1147},{"period":"3month","weight":0.534},{"period":"6month","weight":0.1738},{"period":"1year","weight":1.5078},{"period":"ytd","weight":0.8173}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0101},{"period":"6month","weight":-0.0211},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体（TCR）小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.75,"avgChangeRate":0.087225},{"month":3,"riseRate":0.5,"avgChangeRate":0.15364},{"month":4,"riseRate":0.25,"avgChangeRate":-0.063264},{"month":5,"riseRate":0.5,"avgChangeRate":0.097922},{"month":6,"riseRate":0.25,"avgChangeRate":-0.005144},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006831},{"month":8,"riseRate":0.5,"avgChangeRate":-0.010825},{"month":9,"riseRate":0.75,"avgChangeRate":0.104024},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}